Report copyright - * Finalized June 2015 expenditure numbers not yet ... · Preclinical and Brief Exposure Early Clinical Evaluation of an Oral PARP Inhibitor for Breast Cancer Prevention in BCRA Mutation
Please pass captcha verification before submit form